Analgesic Effects of GpTx-1, PF-04856264 and CNV1014802 in a Mouse Model of NaV1.7-Mediated Pain
- Supplementary File 1:
Supplementary (PDF, 273 KiB)
Deuis, J.R.; Wingerd, J.S.; Winter, Z.; Durek, T.; Dekan, Z.; Sousa, S.R.; Zimmermann, K.; Hoffmann, T.; Weidner, C.; Nassar, M.A.; Alewood, P.F.; Lewis, R.J.; Vetter, I. Analgesic Effects of GpTx-1, PF-04856264 and CNV1014802 in a Mouse Model of NaV1.7-Mediated Pain. Toxins 2016, 8, 78. https://doi.org/10.3390/toxins8030078
Deuis JR, Wingerd JS, Winter Z, Durek T, Dekan Z, Sousa SR, Zimmermann K, Hoffmann T, Weidner C, Nassar MA, Alewood PF, Lewis RJ, Vetter I. Analgesic Effects of GpTx-1, PF-04856264 and CNV1014802 in a Mouse Model of NaV1.7-Mediated Pain. Toxins. 2016; 8(3):78. https://doi.org/10.3390/toxins8030078
Chicago/Turabian StyleDeuis, Jennifer R., Joshua S. Wingerd, Zoltan Winter, Thomas Durek, Zoltan Dekan, Silmara R. Sousa, Katharina Zimmermann, Tali Hoffmann, Christian Weidner, Mohammed A. Nassar, Paul F. Alewood, Richard J. Lewis, and Irina Vetter. 2016. "Analgesic Effects of GpTx-1, PF-04856264 and CNV1014802 in a Mouse Model of NaV1.7-Mediated Pain" Toxins 8, no. 3: 78. https://doi.org/10.3390/toxins8030078